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Background: In 2011–2012, Northern Vietnam experienced its first large scale hand foot and mouth disease (HFMD)
epidemic. In 2011, a major HFMD epidemic was also reported in South Vietnam with fatal cases. This 2011–2012 outbreak
was the first one to occur in North Vietnam providing grounds to study the etiology, origin and dynamic of the disease.
We report here the analysis of the VP1 gene of strains isolated throughout North Vietnam during the 2011–2012 outbreak
and before.
Methods: The VP1 gene of 106 EV-A71 isolates from North Vietnam and 2 from Central Vietnam were sequenced.
Sequence alignments were analyzed at the nucleic acid and protein level. Gene polymorphism was also analyzed.
A Factorial Correspondence Analysis was performed to correlate amino acid mutations with clinical parameters.
Results: The sequences were distributed into four phylogenetic clusters. Three clusters corresponded to the
subgenogroup C4 and the last one corresponded to the subgenogroup C5. Each cluster displayed different
polymorphism characteristics. Proteins were highly conserved but three sites bearing only Isoleucine (I) or Valine (V)
were characterized. The isoleucine/valine variability matched the clusters. Spatiotemporal analysis of the I/V variants
showed that all variants which emerged in 2011 and then in 2012 were not the same but were all present in the
region prior to the 2011–2012 outbreak. Some correlation was found between certain I/V variants and ethnicity and
severity.
Conclusions: The 2011–2012 outbreak was not caused by an exogenous strain coming from South Vietnam or
elsewhere but by strains already present and circulating at low level in North Vietnam. However, what triggered the
outbreak remains unclear. A selective pressure is applied on I/V variants which matches the genetic clusters. I/V variants
were shown on other viruses to correlate with pathogenicity. This should be investigated in EV-A71. I/V variants are an
easy and efficient way to survey and identify circulating EV-A71 strains.
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Hand, foot and mouth disease (HFMD) is an acute
febrile illness in children with a papulovesicular skin
rash at the palms or soles of the feet, or both. Presenta-
tion can be with or without inclusion of mouth ulcers.
Although the disease is usually mild and self-limiting, in
some cases HFMD can result in severe complications
such as encephalitis, aseptic meningitis, pulmonary
edema, myocarditis, and death [29]. HFMD is caused by
members of Human Enterovirus A, a family of picorna-
viridae which includes Coxsackievirus A (CV-A) and
Human Enterovirus 71 (EV-A71) [3, 7]. The EV-A71
viruses are genetically related to CV-A; indeed, it has
been suggested that these viruses may have diverged as
recently as the 1940s [27]. Both EV-A71 and CV-A infec-
tions have been associated with severe HFMD in young
children, sometimes resulting in death [2, 21, 33].
Enteroviruses are characterized by the presence of 4
structural proteins, VP4 being the internal capsid protein
and VP1, VP2 and VP3 making the three external capsid
proteins [6]. VP1 is the most external and is the main
component of the canyon on the surface of picornavi-
ruses. VP1 is involved in viral pathogenicity, receptor
binding and immune modulation of EV-A71 [13, 31].
Differences in EV-A71 strains might contribute to the
different severity of the disease [18, 24] and virulence
determinants have been identified in the VP1 protein such
as residues G/Q/R at position VP1–145, E at VP1–164
[5, 12, 16]. VP1 is used to classify enteroviruses. Based on
the VP1 gene, EV-A71 is classified into three independent
genogroups: A, B, and C. The EV-A71 B and C gen-
ogroups are each further subdivided into five subge-
nogoups, B1 to B5 and C1 to C5 [4].
Although EV-A71 was isolated for the first time in
Vietnam in 2003, the first outbreak of HFMD was not
reported in the southern provinces until 2005. The 2005
outbreak was associated with EV-A71 C1, C4 and C5
genotypes and Coxsackievirus A16 [14, 28]. In 2011, a
major HFMD epidemic was reported in South Vietnam
with fatal cases reported [19]. This 2011–2012 outbreak
was the first one to occur in North Vietnam providing
grounds to study the etiology, origin and dynamic of the
disease. We report here the analysis of the VP1 gene of
strains isolated throughout North Vietnam during the
2011–2012 outbreak.
Methods
Epidemiological information and source of specimens
All HFMD cases in Northern provinces were reported to
the National Institute of Hygiene and Epidemiology
(NIHE) through the national communicable disease sur-
veillance system since 2011. HFMD patients that re-
ported to health centers or hospitals were diagnosed and
classified in 4 severity levels (Additional file 1: Table S1).The evaluation of the disease was performed according
to the guidelines specifically published by the Vietnam-
ese Ministry of Health which are based on WHO and
Taiwanese guidelines [11, 29]. A hundred and eight EV-
A71 throat swabs from North Vietnam and 2 from
Central Vietnam were collected from 2003 to 2012.
Sampling
Ninety four samples were obtained from 94 different
hospitalized patients diagnosed with EV A71 HFMD in
19 out of 28 provinces in North Vietnam in 2011 and
2012 and stored at −80 °C. Fourteen reference samples
obtained from previous cases of EV A71 HFMD between
2003 and 2010 in seven provinces in North Vietnam and
two provinces in Central Vietnam were included in the
study (Table 1). All samples were sent to the Enterovirus
Laboratory of NIHE for etiological assays. Enterovirus-
positive and EV-A71-positive samples were identified
according to Nix et al. [20] using SO (SO224/SO222),
AN (AN88/AN89) and MAS (MAS01S/MAS02A) [22]
primer sets. Viral RNA was directly extracted from
throat swab using QIAamp® Viral RNA Mini Kit (Qia-
gen, Valencia, USA). The cDNA was prepared using the
GoScript™ Reverse Transcriptase kit from Promega.
Seminested RT-PCR was conducted as described by Nix
et al. [20]. The cDNA was first synthesized from the
RNA for 10 min at 25 °C and followed by synthesis of
the second strand at 42 °C for 50 min, 72 °C for 15 min
using primers AN32, AN33, AN34 and AN35 [20]. PCR
was done as described by Nix et al. [20] with 40 cycles
of amplification (95 °C for 30 s, 42 °C for 30 s and, 60 °C
for 45 s). One microliter of the first PCR was used a sec-
ond seminested amplification for 40 amplification cycles
of 95 °C for 30 s, 60 °C for 20 s, and 72 °C for 15 s.
Sequencing was performed with the Sanger method
using the is Bigdye Terminator V3.1 cycle sequencing kit
from Applied Biosystems in an ABI sequencer 3130.
Sequence analyses
Sequences were deposited in GenBank and accession
numbers are provided in Table 1. The VP1 genetic se-
quences were aligned in Seaview 4.6 [10] using Muscle
algorithm [9]. Best-fitting evolutionary models were de-
termined by JModelTest 2.1 [8] or by ProtTest 2.4 [1]
using the corrected version of the Akaike Information
Criterion (AICc). The phylogeny of VP1 was performed
by Maximum Likelihood (ML) inference using the
model GTR + G + F with Seaview 4.6 [10]. The robust-
ness of nodes was assessed with 500 bootstrap replicates.
ML analysis of the amino acid sequences was performed
using the model JTT + I + G with Seaview 4.6 [10]. The
robustness of nodes was assessed with 500 bootstrap
replicates. Sequence polymorphism was investigated
using the DnaSP 5.10.01 package [17]. Amino acid
Table 1 Characteristics of the isolated EV-A71 strains
Strain Age (month) Gender Province Ethnicity Time from onset
to collection (days)
Date Severityf V/I Type Subgenogroup Accession number
2003019 12 NAa Hà Nội NA 4 03/2003 NA VIV C4 KX906272
2005184 0 NA Quảng Nam NA 2 05/2005 NA VVI C5 KX906332
2006023 0 NA Phú Yên NA 3 04/2006 NA VIV C4 KX906278
2007015 24 NA Hà Nam NA 3 01/2007 NA IVI C5 KX906365
2007037 24 NA Yên Bái NA 1 03/2007 NA IVI C5 KX906264
2007041 144 NA Cao Bằng NA 2 03/2007 NA VII C4 KX906262
2007053 30 NA Hải Phòng NA 3 04/2007 NA VII C4 KX906261
2008014 24 1b Nam Định NA 2 05/2008 NA VII C4 KX906263
2008017 30 1 Ninh Bình NA 3 05/2008 NA VII C4 KX906267
2008021 30 2c Ninh Bình NA 2 05/2008 NA IVI C5 KX906299
2008022 24 2 Ninh Bình NA 0g 05/2008 NA IIV C4 KX906273
2008044 30 1 Ninh Bình NA 2 06/2008 NA IVI C5 KX906300
2008065 30 1 Hải Phòng 1d 3 06/2008 1 IVI C5 KX906345
2010002 19 2 Bắc Kạn NA 3 05/2010 NA IVI C5 KX906358
2011011 20 2 Hòa Bình 2e 1 06/2011 1 VII C4 KX906301
2011020 24 2 Hòa Bình 2 1 06/2011 1 VII C4 KX906289
2011022 28 1 Hòa Bình 2 1 06/2011 1 VII C4 KX906315
2011031 72 2 Hà Nội 1 3 06/2011 2a VIV C4 KX906338
2011033 26 1 Hòa Bình 2 1 08/2011 1 VII C4 KX906274
2011034 48 2 Hòa Bình 1 1 06/2011 1 VIV C4 KX906292
2011047 21 1 Sơn La NA 4 07/2011 1 VII C4 KX906269
2011048 22 1 Sơn La NA 4 07/2011 2a VIV C4 KX906352
2011060 21 2 Thanh Hóa 1 3 06/2011 2a VVV C4 KX906265
2011063 24 1 Hòa Bình 1 2 07/2011 1 VII C4 KX906290
2011095 19 1 Hòa Bình 2 1 07/2011 1 VII C4 KX906337
2011096 12 2 Hòa Bình NA 3 07/2011 1 VII C4 KX906308
2011097 7 1 Hòa Bình 1 6 09/2011 1 VII C4 KX906335
2011117 42 1 Thanh Hóa 1 3 07/2011 2a IIV C4 KX906350
2011123 12 2 Hòa Bình 2 0 07/2011 1 VIV C4 KX906281
2011124 9 1 Hòa Bình 2 1 07/2011 1 VII C4 KX906329
2011125 13 1 Hòa Bình NA 1 07/2011 1 VII C4 KX906368
2011158 11 2 Hòa Bình NA 2 08/2011 1 IVI C5 KX906309
2011161 21 1 Hòa Bình 2 0 07/2011 1 VII C4 KX906296
2011165 22 1 Hòa Bình 1 1 08/2011 1 VII C4 KX906349
2011278 21 1 Nam Định 1 2 08/2011 1 VVV C4 KX906310
2011282 23 1 Nam Định 1 0 08/2011 1 IIV C4 KX906343
2011340 2 1 Lào Cai 2 1 08/2011 2a VII C4 KX906293
2011488 60 2 Hòa Bình NA 2 09/2011 1 VII C4 KX906319
2011490 38 1 Hòa Bình 2 1 09/2011 1 VII C4 KX906276
2011521 43 2 Hà Nội 1 3 09/2011 1 VVV C4 KX906305
2011571 32 1 Hòa Bình 2 1 09/2011 1 VIV C4 KX906331
2011573 12 1 Hòa Bình NA 1 09/2011 1 VII C4 KX906307
2011575 12 1 Hòa Bình 2 4 09/2011 1 VIV C4 KX906341
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2011579 46 1 Hà Nội 1 2 09/2011 1 IIV C4 KX906277
2011586 20 2 Hà Nội 1 3 09/2011 2a IIV C4 KX906366
2011598 26 1 Thanh Hóa 2 1 09/2011 1 VII C4 KX906339
2011600 51 1 Bắc Kạn 1 7 10/2011 2a VIV C4 KX906355
2011647 22 2 Thanh Hóa 1 8 10/2011 2a VII C4 KX906268
2011662 11 1 Hà Nội 1 2 10/2011 1 IIV C4 KX906297
2011664 16 2 Hà Nội 1 1 10/2011 2a IIV C4 KX906325
2011665 11 2 Hà Nội 1 3 10/2011 1 IIV C4 KX906266
2011676 4 1 Điện Biên 2 3 10/2011 1 IIV C4 KX906271
2011677 13 1 Điện Biên 1 3 10/2011 1 IIV C4 KX906322
2011679 12 1 Thanh Hóa NA 4 10/2011 1 IIV C4 KX906270
2011754 8 1 Hòa Bình NA 10 10/2011 1 IIV C4 KX906334
2011799 12 1 Thanh Hóa 1 2 10/2011 2b VII C4 KX906275
2011805 9 2 Thanh Hóa 2 3 10/2011 2a VII C4 KX906286
2011816 22 1 Điện Biên 2 8 10/2011 2a IIV C4 KX906357
2011823 32 2 Tuyên Quang 1 10 04/2011 1 IIV C4 KX906364
2011835 18 1 Hà Nội 1 2 11/2011 1 VII C4 KX906313
2011840 15 2 Hà Nội 1 3 11/2011 2a VII C4 KX906340
2011866 26 2 Bắc Ninh 1 2 11/2011 1 IIV C4 KX906354
2011868 52 2 Bắc Kạn 1 5 11/2011 1 VIV C4 KX906330
2011872 13 2 Điện Biên 1 2 11/2011 2a IIV C4 KX906347
2011881 26 2 Hải Phòng 1 3 11/2011 2b VII C4 KX906360
2011882 25 1 Hải Phòng 1 6 11/2011 2b IIV C4 KX906287
2011888 25 2 Hải Phòng 1 4 11/2011 2b VII C4 KX906333
2011891 26 1 Thanh Hóa 1 3 11/2011 1 VII C4 KX906361
2011894 20 1 Hải Phòng 1 5 11/2011 2a IIV C4 KX906312
2011896 17 2 Hải Phòng 1 5 11/2011 2b IIV C4 KX906336
2011897 11 1 Hải Phòng 1 6 11/2011 2b VIV C4 KX906317
2011925 13 2 Hải Phòng 1 1 11/2011 2b IIV C4 KX906363
2011927 41 2 Hòa Bình 1 3 11/2011 1 VII C4 KX906283
2011956 64 2 Tuyên Quang 2 13 11/2011 3 VII C4 KX906304
2011958 26 1 Tuyên Quang 2 7 11/2011 3 VII C4 KX906323
2011970 32 1 Hà Nội 1 1 11/2011 2a IIV C4 KX906298
2011984 13 1 Hải Phòng 1 5 12/2011 2a IIV C4 KX906327
2012018 18 2 Hải Dương 1 3 02/2012 1 IVI C5 KX906295
2012019 18 1 Hải Dương 1 1 02/2012 1 VIV C4 KX906353
2012053 12 1 Lào Cai 1 3 02/2012 2a VIV C4 KX906359
2012095 20 1 Bắc Giang 1 1 03/2012 2a IIV C4 KX906367
2012114 20 1 Lào Cai 1 1 03/2012 2a VII C4 KX906303
2012117 20 1 Lào Cai 2 2 03/2012 1 IVI C5 KX906280
2012126 11 1 Hải Phòng 1 5 03/2012 2b IIV C4 KX906346
2012151 13 1 Hải Dương 1 2 03/2012 1 VII C4 KX906320
2012159 36 2 Phú Thọ 1 3 03/2012 2a VIV C4 KX906314
2012161 16 1 Phú Thọ 1 4 03/2012 2a VIV C4 KX906302
2012164 27 1 Phú Thọ 2 2 02/2012 1 IIV C4 KX906306
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2012165 54 1 Phú Thọ 2 0 02/2012 1 IIV C4 KX906362
2012166 14 1 Phú Thọ 1 5 03/2012 1 VIV C4 KX906356
2012169 5 2 Phú Thọ 1 3 03/2012 1 IVI C5 KX906294
2012189 15 1 H i Dương NA 5 03/2012 1 VIV C4 KX906285
2012225 7 1 Hà Nội 1 5 03/2012 3 VIV C4 KX906348
2012233 40 1 Bắc Kạn 2 5 03/2012 1 IIV C4 KX906351
2012237 84 2 Bắc Giang 1 3 03/2012 2b IVI C5 KX906288
2012260 25 1 Thanh Hóa 1 2 03/2012 1 VIV C4 KX906311
2012262 30 1 Thanh Hóa NA 3 03/2012 NA VIV C4 KX906328
2012264 9 1 Thanh Hóa 1 3 03/2012 1 IVI C5 KX906284
2012271 34 1 Ninh Bình 1 1 03/2012 1 IVI C5 KX906279
2012284 44 2 Hải Phòng 1 2 03/2012 2b IVI C5 KX906282
2012296 24 2 Sơn La NA 2 03/2012 NA VII C4 KX906344
2012297 22 1 Tuyên Quang 1 13 03/2012 1 VII C4 KX906342
2012300 28 1 Tuyên Quang 1 9 03/2012 1 VIV C4 KX906326
2012319 57 2 Bắc Kạn 2 0 03/2012 1 VIV C4 KX906318
2012353 17 2 Hà Nội 1 3 04/2012 1 VII C4 KX906316
2012387 17 2 Lai Châu 1 3 04/2012 2a IVI C5 KX906291
20111000 14 2 Hải Phòng 1 3 12/2011 2b IIV C4 KX906324
20111003 19 1 Hải Phòng 1 5 12/2011 2b VIV C4 KX906321
a)NA: Not Available
b)Gender 1 = Male
c)Gender 2 = Female
d)Ethnicity 1 = Main Vietnamese ethnic group
e)Ethnicity 2 = Hmong ethnic minority
f)Severity is classified according to five scores: 1, 2a, 2b, 3 and 4.1 and 2a are mild cases and 2b to 4 are severe cases. The description of each stage is given in
Additional file 1: Table S1
g)“0” means that admission occurred the same day as onset
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tein using the sequence HQ129932.1 [16] as a reference.Bias and ethics
Training session on HFMD cases definition and report-
ing were organized for the staff of the routine surveil-
lance system to enhance quality and consistency of case
report. This work was conducted following the require-
ments of the Vietnamese Ministry of Health and under
the Law of Communicable Diseases Prevention and
Control passed in 2007.Factorial correspondence analysis
A factorial correspondence analysis (FCA) was performed
using XLSTAT software (Addinsoft®). Variables considered
were: amino acid profiles on positions 151, 164 and 186
(V/I), respectively in this work (249, 262 and 284 on the
full length VP1 protein), severity level, ethnicity, age of pa-
tients, and patient location. The best descriptive axes were
retained, explaining 34% of the data spread. Potentialcorrelations were confirmed by a test of contingency using
Statview 5.0 software (SAS Institute Inc.)
Spatio-temporal analysis
Administration data were obtained from GADM database
of Global Administrative Areas (version 2.8, November
2015). Spatial analyses were conducted with Quantum
GIS, version 2.8.2. All spatial data are in the WGS 84
coordinate system.
Results
Clinical and epidemiological features
Data are shown in Table 1. Patients age ranged from
2 months to 12 years old (median at 1.8 years, IQR of
1.5 years). 102/106 (96.23%) patients were under 5. The
age-specific incidence highest in the 1–2 years age group
(44 cases, 41.51%) and remained very low for older chil-
dren. The lowest incidence was observed in infants
under 6 months (2.83%) and children above 10 years old
(0.94%). Patients came from all parts of the region in-
cluding mountainous, rural and urban areas. Out of 83
Duy et al. BMC Infectious Diseases  (2017) 17:333 Page 6 of 12cases, 59 (71.08%) belonged to main Vietnamese ethni-
city (Ethnicity 1) while the rest of patients belonged to
the minority Hmong ethnicity (Ethnicity 2) (Table 1). All
severity levels were reported for the patients. Mild forms
(severity level 1) made the majority of cases (57 cases,
61.29%) while 15 patients displayed severe symptoms
(16.13%). Among this group, 3 patients displayed a
severity score of 3. No case with the highest level of
4 was recorded. Moderate forms of HFMD were
found in 21 patients (22.58). (Table 1).
VP1 phylogeny and population structure
Phylogenetic analysis of the VP1 gene sequences indi-
cated the presence of four clusters (Fig. 1). Cluster 1, the
closest to the root, was the main one, comprising 56 se-
quences and structured into several subclusters charac-
terized by low bootstrap values. Cluster 2 and cluster 3
comprised respectively 23 and 12 sequences and segre-
gated from cluster 1 to which they were separated with a
low bootstrap of 30. The last cluster, cluster 4, compris-
ing 17 sequences was characterized by a high bootstrap
value (100) and was a derivate from cluster 3. A similar
tree topology was observed when using protein align-
ments (Data not shown). With respect to the current
genogroup classification, clusters 1, 2 and 3 belonged to
the subgenogroup C4 whereas cluster 4 belonged to the
subgenogroup C5 (Table 1). The VP1 protein was char-
acterized by a high rate of conservation. However, three
sites displayed a consistent Valine (V) / Isoleucine (I)
variation (Fig. 2). These sites, sites A, B and C were lo-
cated in the VP1 protein at position 814, 827 and 849 of
the polyprotein. Six types of I/V variants were observed
when considering the amino acids at sites A, B and C:
VVI (1 sequence), IVI (15 sequences), IIV (28 se-
quences), VII (38 sequences), VIV (23 sequences) and
VVV (3 sequences) (Table 1). When attributing a color
code for each I/V variant population and applying it to
the phylogenetic tree a clear overlap with the previously
detected clusters was observed (Fig. 1). Cluster 4 over-
lapped with the IVI population while clusters 2 and 3
comprised the VII variants. The VVV, IVV and VIV vari-
ants all corresponded to cluster 1. However they did not
mix and each one corresponded to a specific subcluster.
The VVI variant derived from the cluster 4 / IVI group.
Three exceptions were found, with VII variants present
in clusters 1 and 4. With respect to phylogeny, the I/V
variant closest to the root is VVV, the VIV population
emerged from this group and gave rise in turn to the IIV
group. The VII groups, derived from the VIV group with
first cluster 2 from which cluster 3 evolved. The well
separated cluster 4/IVI variants evolved from cluster 3.
This overlap between clusters and I/V populations was
even stronger at the protein level since almost all the
variability was borne by the I/V mutations, the rest ofthe protein being highly conserved. Groups VII, IIV,
VVV and VIV belonged to the subgenogroup C4
whereas groups IVI and VVI belonged to the subge-
nogroup C5.
Nucleic acid polymorphism
When considering the polymorphism of the various
clusters identified, very different traits were observed
(Table 2). Cluster 1 was polymorphic (θ = 14.58) but
with a 2.5 times more parsimony informative sites than
singletons and 10-times more synonymous mutations
than non-synonymous ones, suggesting that it is not a
recent polymorphism or expanding population. The Ka/
Ks ratio was also characterized by a low value. Con-
versely, cluster 2 displayed a very low level of poly-
morphism with a q of 4.06 and a low number of
mutations η (η = 15). The Ka/Ks was slightly higher at
0.107. This is suggesting the existence of a bottleneck at
the origin of cluster 2. Cluster 3 which originated from
cluster 2 was more polymorphic with a slightly increas-
ing θ (θ = 6.92) and number of mutations η (η = 19).
Only synonymous mutations were observed resulting in
turn in a very low Ka/Ks ratio of 0.029. Cluster 4 was on
the other hand displaying a very high polymorphism
with a η of 113 for 109 and a very high level of syn-
onymous mutations (105 out of 110) suggesting a strong
negative selection acting on a mutating population. As a
consequence, the Ka/Ks ratio was also very low at 0.011.
Distribution of mutations and correlation analysis
The correlation analysis indicated a partial structuration
of cases (34% of dispersion explained) on different pa-
rameters (Fig. 3). The VVI variant was not included in
the analysis because all information was not available.
The analysis was therefore conducted on only five vari-
ants, i.e. IIV, VII, IVI, VIV and VVV. Severity of HFMD
seemed to correlate with the age of patient (p = 0.011)
and the highest severity level was not observed above
11-month old. The VII variant segregated from the other
variants on the F1 axis and was associated with both low
severity (p = 0.025) and with the ethnicity-2 group,
56.5% of patients from this ethnicity-2 group were in-
fected by the VII variant, but this represented only
46.4% of all samples harboring the VII protein
(p = 0.006). No variant was specifically associated with
the highest severity (p = 0.99) whereas the IIV variant
was correlated with mild severity (p = 0.003).
Spatiotemporal distribution of the virus populations
I/V variants present in the 2011 outbreak belonged
mostly the IIV and VII populations which were already
present in Northern Vietnam (Fig. 4a) The IIV popula-
tion was previously detected in 2008 in the Ninh Binh
province whereas VII variants were detected in Cao
Fig. 1 Phylogenetic analysis of partial VP1 sequences. a Phylogenetic analysis of the nucleic acid sequences.Tree was designed using Maximum
Likelihood. Color code: Black: VVV; Light blue: VII; Yellow: IIV; Purple: VIV; Dark blue: VVI
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Fig. 2 Multiple alignment of VP1 proteins. The three sites analyzed in this work are marked by arrows
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Ninh Binh 2008. VII and IIV variants represented 46%
and 33.3% of the samples collected in 2011, respectively
(Fig. 4b, d). Other mutant populations detected in 2011
were: IVI (1.7%) already detected in 2007 in Yen Bai and
Han Nam, in 2008 in Ninh Binh and in 2010 in Hai
Phong and Bac Kan; VIV (14.3%) previously found in
2003 in Ha Noi and in 2006 in Phu Yen; and VVV
(4.8%) (Fig. 4a). The VVV variants were not detected in
samples collected prior to the 2011–212 outbreak. The
mutant populations detected in 2012 were IIV and VII
whose prevalence was reduced to 16.2% and 19.3% and
VIV and IVI which prevalence rose to 38.7% and 25.8%,
respectively (Fig. 4c, d). The VVV mutant was foundTable 2 Polymorphism and divergence data
N Hp Nt S η
Cluster 1 56 43 561 67 70 48
Cluster 2 23 15 561 15 15 9
Cluster 3 12 10 561 19 19 11
Cluster 4 17 13 561 109 113 57
Total 108 81 561 148 162
N Number of sequences
Hp Number of haplotypes
Nt Sequence size in nucleotides
S Number of mutated sites
η Number of mutations
Pa Number of parsimony informative sites
Si Number of singletons
θ Number segregating sites (per sequence from S)
MC Number of mutated codons
Na Number of non-synonymous mutations
Ns Number of synonymous mutations
Ka/Ks Ka/Ks ratioonly in 2011 in Thanh Hoa, Nam Dinh and Ha Noi
(Fig. 4b, d). With respect to spatial distribution, the
rise of variants VII and IIV observed in 2011 was not lo-
cated in a specific area but covered most of the sampling
sites (8 out of 11). The replacement of the IIV and VII var-
iants by the IVI and VIV variants followed a similar pat-
tern confirming the wide-spread diffusion of the outbreak.
The number of sites with more than two variants was
higher in 2011 than in 2012. The IIV variant was the most
widely spread in 2011 but became the least widely spread
in 2012 (Fig. 4b, c). Conversely, the IVI variant which was
the least widely spread in 2011 and found in only one
province, i.e. Hoa Binh, became the most widely spread in
2012. The VVV variant was found only in 2011 in threePa Si θ MC Na Ns Ka/Ks
19 14.58 64 6 58 0.053
6 4.06 15 6 9 0.107
8 6.92 16 0 16 0.029
52 32.24 110 5 105 0.011
128 20 28.16 147 9 138 0.019
Fig. 3 Factorial correspondence analysis. Variables analyzed were: amino acid profiles on positions 151, 164 and 186 (V/I), respectively in this work
(249, 262 and 284 on the full length VP1 protein), severity level, ethnicity, age of patients, and patient location
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each time in association with the IIV variant (Fig. 4b, c).
The VVI variant was detected only in Quang Nam,
Central Vietnam and prior to 2011.
Discussion
This work provides an insight on the evolution and
dynamics of the EV-A71 enterovirus during the first out-
break recorded in North Vietnam in 2011–2012. The
first conclusion is that the 2011–2012 outbreak in North
Vietnam was not due to a single exogenous strain
imported from South Vietnam where HFMD outbreaks
were present [19] or from another region. All variant
populations observed during the 2011–2012 outbreak
were already present in North Vietnam. The only excep-
tion is the VVV population which was found only in
2011 in three different provinces. However, the phylo-
genetic analysis indicated that this VVV variant was the
closest to the root and therefore to the mother and old-
est population. The reason for the lack of VVV variants
in samples older than 2011 is most likely related to the
low number of samples and to the low prevalence of thispopulation. Furthermore, this 2011–2012 outbreak was
also characterized by the cocirculation of the same four
variant populations with a replacement between 2011
and 2012. The VII and IIV variants which were the most
prevalent in 2011 were replaced by IVI and VIV popula-
tions in 2012. There is no clear explanation for the re-
placement of the main variant populations between 2011
and 2012 but it could be related to immunoresistance
acquired during the first half of the outbreak in 2011
The surge of variants VII and IIV in the first part of the
epidemic could not be related to any measured parame-
ters and altogether the question remains of what trig-
gered the outbreak in 2011 although all virus
populations were already present. All I/V populations
present at the beginning of the outbreak were capable of
triggering it as shown by the replacement in 2012. It is
not related either to the subgenogroup since the popula-
tions which emerged in 2012 belonged to two different
subgenogroups, the VIV variant belonging the subge-
nogroup C4 and the IVI variant being a member of sub-
genogroup C5. A partial explanation could be a
differential susceptibility of the human population which
Fig. 4 Spatiotemporal distribution of I/V variants. Color code: Black: VVV; Light blue: VII; Yellow: IIV; Purple: VIV; Dark blue: VVI
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IIV groups. Another explanation might be found in the
spatial distribution of the various variant groups, the
socio-economic pattern and the route of dissemination.
This work was not structured to address this issue and
specific sampling schemes as well as transversal analyses
should thus be further undertaken.
Another main outcome of this work is the observed
correlation between I/V variant groups and phylogeny,
pathogenicity and ethnicity. One hypothesis is that fix-
ation of mutations in VP1 could be related to the VP1
function itself. Li et al. [16] reported virulentdeterminants in VP1 located at position 710 and 729
with Glutamic acid, Glycine or Arginine being associated
to severe cases at position 710 and Glutamic acid at pos-
ition 729 being also a marker of severity. In this study
we didn’t see this correlation with position 710 bearing
90 Glutamic acid, 6 Glycine and 12 Glutamine and pos-
ition 729 bearing 107 Aspartic acid and 1 Glycine both
out of 108 sequences. These amino acids were found in
strains associated to mild and moderately severe cases.
No highly severe case was found in this work. I/V
groups, although based on the relative arrangement of
only three amino-acids, overlap the different clusters
Duy et al. BMC Infectious Diseases  (2017) 17:333 Page 11 of 12identified. These clusters correspond to genetically differ-
ent populations characterized by specific polymorphism
traits. This overlap between the specific combination of I/
V residues at three positions and the phylogeny estab-
lished on the nucleotide sequences suggests the occur-
rence of a selective pressure on the I/V arrangement. The
high conservation of the proteins, despite variability at the
nucleotide level, indicative of a negative, or purifying, se-
lection pressure, indicates that the clustering at the pro-
tein level is driven by the I/V arrangement. The remaining
question is what is the selective pressure acting on I/V
variants and what could be the role of these I/V muta-
tions. I/V mutations are located in the VP1 protein at po-
sitions 814, 827 and 849 of the polyprotein. The region
from amino acid 697 to 862 on the EV-A71 polyprotein at
the level of the VP1 protein was shown to be crucial for
increasing the strength of protein-protein interactions in
the capsid and its stability. This increased stability strongly
enhances the pathogenicity and survival of the virus in the
gastrointestinal track [15]. Isoleucine and valine are ali-
phatic hydrophobic amino acid mediating the core struc-
ture of the protein and have been reported to be involved
in virulence and pathogenicity in several viruses, coxsack-
ievirus B3 [25], Moloney murne Leukemia Virus [26], In-
fectious Bursal Disease virus [32], Japanese Encephalitis
virus [30], and Simian-Human Immunodeficiency Virus
[23]. The recurrent reports of the involvement of isoleu-
cine and valine in the viral pathogenicity process in differ-
ent viruses as well as their involvement in the selective
pressure applied on the EV-A71 isolates analyzed in this
work suggest that the I/V pattern at positions 249, 262 and
284 on the VP1 protein might indeed play a role in patho-
genicity. The observed correlation of I/V variant popula-
tions with severity and ethnicity strengthen this hypothesis.
However, the ethnicity correlation could be a result of
spatial structuration since ethnicity-2 is mostly present in
the Hòa Bình province. This in turn would suggest that the
various EV-A71 variants display a geographic specificity.
Conclusion
Altogether, these data suggest that EV-A71 strains could
remain in a low level, asymptomatic state, in genomic
stasis and with a geographic structuration. The cause for
outbreaks should thus be sought for in the socio-
economic patterns rather than in exogenous emergence.
Further investigations are needed to investigate this
hypothesis and to bring valuable information for the
management of this major pediatric disease.Additional file
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